• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 5. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Methyl 6-Amino-5-iodopyridine-3-carboxylate (CAS No. 211308-80-4): A Key Intermediate in Modern Pharmaceutical Synthesis

Methyl 6-Amino-5-iodopyridine-3-carboxylate, identified by its CAS number 211308-80-4, is a highly valuable intermediate in the realm of pharmaceutical synthesis. This compound, characterized by its pyridine core structure modified with an amino group at the 6-position, an iodine atom at the 5-position, and a carboxylate ester at the 3-position, has garnered significant attention due to its versatile applications in drug development.

The structural attributes of Methyl 6-Amino-5-iodopyridine-3-carboxylate make it an ideal candidate for further functionalization, enabling the synthesis of a wide array of pharmacologically active molecules. The presence of the iodine atom, in particular, facilitates cross-coupling reactions such as Suzuki-Miyaura and Stille couplings, which are pivotal in constructing complex organic frameworks. These reactions are widely employed in the medicinal chemistry community to create novel heterocyclic compounds with potential therapeutic benefits.

In recent years, there has been a surge in research focused on developing treatments for various diseases, including cancer and infectious disorders. Methyl 6-Amino-5-iodopyridine-3-carboxylate has emerged as a crucial building block in the synthesis of targeted therapies. For instance, researchers have leveraged this compound to design small-molecule inhibitors that selectively interact with specific biological pathways dysregulated in diseases like oncology.

One of the most compelling applications of Methyl 6-Amino-5-iodopyridine-3-carboxylate is in the development of radiolabeled probes for positron emission tomography (PET) imaging. The iodine atom can be easily incorporated into radiopharmaceuticals, allowing for non-invasive visualization of biological processes at the molecular level. This has opened new avenues for diagnostic applications, particularly in oncology and neurology, where early detection and precise targeting are critical.

The compound's utility extends beyond diagnostics; it also plays a pivotal role in the synthesis of kinase inhibitors. Kinases are enzymes that play a central role in cell signaling pathways, and their dysregulation is implicated in numerous diseases. By incorporating Methyl 6-Amino-5-iodopyridine-3-carboxylate into drug candidates, chemists can design molecules that selectively inhibit aberrant kinase activity, thereby mitigating disease progression.

Recent advancements in synthetic methodologies have further enhanced the appeal of Methyl 6-Amino-5-iodopyridine-3-carboxylate. Techniques such as flow chemistry and microwave-assisted synthesis have enabled more efficient and scalable production processes. These innovations not only improve yield but also reduce waste, aligning with the growing emphasis on sustainable pharmaceutical practices.

The impact of Methyl 6-Amino-5-iodopyridine-3-carboxylate on drug discovery is underscored by its frequent use in high-throughput screening (HTS) campaigns. HTS allows researchers to rapidly test thousands of compounds for biological activity, expediting the identification of lead candidates. The structural diversity offered by this intermediate has been instrumental in identifying novel therapeutic agents with promising preclinical profiles.

In conclusion, Methyl 6-Amino-5-iodopyridine-3-carboxylate (CAS No. 211308-80-4) represents a cornerstone in modern pharmaceutical synthesis. Its unique structural features and reactivity make it an indispensable tool for medicinal chemists seeking to develop innovative treatments for a myriad of diseases. As research continues to evolve, it is likely that this compound will remain at the forefront of drug discovery efforts, contributing to significant advancements in human health.

• 54400-30-5(2-Amino-5-iodonicotinic acid)
• 848093-36-7(Ethyl 2-amino-5-iodonicotinate)
• 543740-75-6(Ethyl 6-amino-5-iodo-3-pyridinecarboxylate)
• 680208-83-7(methyl 6-amino-5-iodo-2-methyl-pyridine-3-carboxylate)
• 1227048-78-3(Methyl 2-amino-5-iodonicotinate)
• 543740-89-2(6-Amino-5-iodonicotinic acid)
• 36052-24-1(methyl 6-aminopyridine-3-carboxylate)
• 848093-39-0(3-Pyridinecarboxylic acid, 2-amino-5-iodo-, 2-propenyl ester)
• 849805-80-7(3-Pyridinecarboxylic acid, 2,6-diamino-5-iodo-, ethyl ester)
• 1033955-80-4(Methyl 5-iodopyridine-3-carboxylate)